Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: In its latest Strategy Update, the U.N. agency said that the world stands at a "pivotal juncture" in the pandemic and that "speed, scale, and equity must be our guiding principles" when deciding what measures are necessary. Every country should implement comprehensive public health measures to maintain a sustainable steady state of low-level or no transmission and prepare its surge capacity to react rapidly to control any spread, the WHO said. Some of the countries hardest-hit by the virus are now considering lifting lockdowns and beginning the transition toward a resumption of normal life. The WHO update said any such steps should be taken gradually, with time to evaluate their impact before new steps are taken. "To reduce the risk of new outbreaks, measures should be lifted in a phased, step-wise manner based on an assessment of the epidemiological risks and socioeconomic benefits of lifting restrictions on different workplaces, educational institutions, and social activities...," the WHO said. "Ideally there would be a minimum of 2 weeks (corresponding to the incubation period of COVID-19) between each phase of the transition, to allow sufficient time to understand the risk of new outbreaks and to respond appropriately," it added. It warned that the "risk of re-introduction and resurgence of the disease will continue". The Geneva-based global health organisation issued its advice at a time when it has come under criticism from the United States for its initial response to the pandemic. President Donald Trump said on Tuesday Washington, the WHO's biggest donor, would suspend funding. China has begun lifting some of the toughest restrictions imposed on Hubei province where the disease first emerged at the end of last year. In the United States, which has the largest number of confirmed cases and deaths, Trump has jostled with some state governors over who has the authority to begin reopening U.S. businesses. European countries have begun small-scale steps to reduce severe lockdowns. Some Spanish businesses, including construction and manufacturing, have been allowed to resume, although shops, bars and public spaces are to stay closed until at least April 26. Italy, which has the world's second-highest death toll at 21,067, maintained some tight restrictions on movement, while Denmark, one of the first European countries to shut down, will reopen daycare centres and schools for children in first to fifth grades on Wednesday.
[EX A]: Lockdowns should be lifted in two-week stages to stem COVID-19 spread: WHO.

[EX Q]: The company has since mid-March launched three coronavirus tests, including an antibody test crucial in identifying immunity among people and one that can deliver results within minutes, which was heralded as a game changer by President Donald Trump. Shares of the company were up 6% at $96.48 in morning trading. Despite the strong uptake in coronavirus testing, the cancellation of non-essential surgeries and restrictions on people's movement are expected to severely crimp sales of its medical devices and other lab tests, which contribute to more than half of total quarterly revenue. "(The second quarter) will likely be our toughest quarter in the year, especially for our core lab business, our cardio and neuro businesses," Chief Executive Officer Robert Ford said on a post-earnings call. The company suspended its full-year forecast due to the uncertainty caused by the health crisis and said it expects to provide an update in the second half of the year. Abbott projected a recovery in elective procedures and testing volumes globally from the third quarter and said it was seeing signs of stabilization in China and areas where the outbreak has begun to abate. "We're all hoping for a fast recovery here, but if it takes longer, we'll have strong demand for testing and that will continue to help buffer the impact," Ford said. Elective procedure declines were at the core of Johnson & Johnson's (JNJ.N) decision to cut 2020 forecasts on Tuesday, with recovery expected in the second half of the year. Abbott beat first-quarter earnings expectations as shelter-in-place restrictions imposed by U.S. states boosted demand for nutrition products for children such as PediaSure, lifting sales in the unit by 6.3% to $1.90 billion. Results were also boosted by a strong flu season before the outbreak that helped minimize testing declines and on softer-than-expected COVID-19 impact across businesses, said J.P. Morgan analyst Robbie Marcus. Sales in the diagnostics unit fell nearly 1% to $1.83 billion, while demand for its FreeStyle Libre diabetes monitoring device remained strong fueled by expanded insurance coverage in Japan. Sales of the device surged 60% to over $600 million. Excluding items, the company earned 65 cents per share, beating expectation of 58 cents. Net sales of $7.73 billion also topped estimates of $7.34 billion.
[EX A]: Coronavirus test ramp-up to help Abbott weather 'toughest quarter'.

[EX Q]: A bill that would allow trained pharmacists to administer the influenza vaccine to children 12 years and older cleared the General Assembly's Public Health Committee in a 17-7 vote this year, but it later died on the Senate calendar due to inaction. Bill supporter, Nathan Tinker, CEO of the Connecticut Pharmacists Association, said his organization doesn't plan to push hard for it again in the next regular legislative session because he is worried the debate over the General Assembly's efforts to scrap a religious exemption for some vaccines will ultimately spill over into discussions about the flu shot and likely doom the bill in the short, three-month session. "There is a community of people who are concerned about the impact or potential impact, whether real or perceived, about vaccines," Tinker said. "And they get a lot of attention from legislators and that can make it difficult." When the new legislative session opens in February, lawmakers are expected to consider ending the state's longstanding religious exemption after newly released data showed a continued decline in immunization rates for measles, mumps and rubella among kindergarteners. That proposal has already met resistance and some of the concerns raised are like the ones voiced during this year's discussion of the flu vaccine bill. Legislators were flooded with testimony earlier this year from parents with concerns about whether making the vaccine more convenient could lead to injuries that pharmacists might not be trained recognize. Others questioned the motives of the pharmaceutical industry and necessity of flu shots. Dr. Sandra Carbonari, a primary care pediatrician in Waterbury and the medical director of the Connecticut Chapter of the American Academy of Pediatrics, also opposed the bill, but for different reasons. She questioned whether state regulations for providing the flu vaccine to children who receive Medicaid benefits might ultimately make the shot too expensive, and whether DPH's vaccine program can handle a large increase in the number of providers. She also noted that immunizing a child can be complicated. "Determining the appropriate vaccine for a pediatric age patient is not simple and requires accurate information about the medical history and current state of health," she said in written testimony. Supporters of the flu shot bill argue that allowing parents to drop by a pharmacy, rather than make an appointment with a pediatrician, would ultimately lead to higher flu immunization rates. The bill had the support of the state's Department of Public Health, which noted three children in Connecticut died from flu-related complications during the 2017-18 flu season. Pharmacists in Connecticut are currently allowed to vaccinate people 18 years or older. According to DPH, individuals under 18 can be administered the flu vaccine by advanced practice registered nurses at retail locations, such as a CVS MinuteClinic. Sen. Heather Somers, of Groton, the top Senate Republican on the Public Health Committee who co-sponsored this year's bill, stressed that the legislation is voluntary and requires the consent of a parent or guardian. Somers contends the legislature just ran out of time to act on the bill earlier this year, and she plans to resurrect it when lawmakers convene again in February for the 2020 session. "This is something that saves lives," said Somers, who helped to organize a mobile flu clinic in her district last year. "I think accessibility is key in our health care system."
[EX A]:
Bill allowing pharmacists to give kids the flu shot at risk.